了解公众对纳洛的看法:常见问题和答案来源可信度的研究
Sydney C Ferrell1, Matthew C Ferrell1, Cole M Nelson2
1Department of Internal Medicine, The University of Vermont Medical Center, Burlington, Vermont, USA.
Substance use & misuse
|April 30, 2024
概括
纳洛是一种阿片类药物过量干预措施,很快将在非处方药店上市. 这项研究分析了网上关于纳洛的常见问题 (FAQ),发现需要提高网站信息的准确性和可访问性.
科学领域:
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
背景情况:
- 纳洛是阿片类药物过量使用的主要干预措施.
- 美国即将推出的非处方药的可用性需要可访问的公共信息.
- 了解公众对纳洛的知识差距至关重要.
研究的目的:
- 分类关于纳洛的常见问题 (FAQ) 和它们的答案.
- 分析纳洛常见问题在线信息来源.
- 评估在线纳洛信息的质量和可信度.
主要方法:
- 在谷歌上搜索"narcan"和"naloxone"以确定常见问题和来源.
- 将问题分为事实,政策和价值类别.
- 使用JAMA基准标准和统计分析评估网站的可信度.
主要成果:
- 确定了305个关于纳洛的独特常见问题.
- 政府和商业实体是最常见的来源 (38.2%和32.6%).
- 在不同类型的来源中发现了可信度得分的显著差异,学术和政府来源的表现更好.
结论:
- 发现了公众对纳洛的理解和知识的差距.
- 建议更新在线资源,以提高准确性和实用性.
- 强调需要可靠的信息,因为纳洛变得更容易获得.
更多相关视频
07:50A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
9.6K
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.7K
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Delivery: Enteral Route
428
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
428
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Pharmacovigilance
829
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
829
Opioid Receptors: Overview
761
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
761
Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
